BS Iso 28620-1010
BS Iso 28620-1010
BS Iso 28620-1010
28620:2010
ICS 1 1. 040. 20
National foreword
STANDARD 2 862 0
First edition
201 0-02-1 5
portabl e i n fu s i on d e vi ces
Reference number
ISO 28620:201 0(E)
© ISO 201 0
BS ISO 28620:2010
I S O 2 8 62 0 : 2 0 1 0(E )
P D F d i s cl ai m er
This PDF file may contain embedded typefaces. In accordance with Adobe's licensing policy, this file may be printed or viewed but
shall not be edited unless the typefaces which are embedded are licensed to and installed on the computer performing the editing. In
downloading this file, parties accept therein the responsibility of not infringing Adobe's licensing policy. The ISO Central Secretariat
accepts no liability in this area.
Adobe is a trademark of Adobe Systems Incorporated.
Details of the software products used to create this PDF file can be found in the General Info relative to the file; the PDF-creation
parameters were optimized for printing. Every care has been taken to ensure that the file is suitable for use by ISO member bodies. In
the unlikely event that a problem relating to it is found, please inform the Central Secretariat at the address given below.
© ISO 201 0
All rights reserved. Unless otherwise specified, no part of this publication may be reproduced or utilized in any form or by any means,
electronic or mechanical, including photocopying and microfilm, without permission in writing from either ISO at the address below or
ISO's member body in the country of the requester.
ISO copyright office
Case postale 56 • CH-1 21 1 Geneva 20
Tel. + 41 22 749 01 1 1
Fax + 41 22 749 09 47
E-mail copyright@iso.org
Web www.iso.org
Published in Switzerland
C on ten ts Page
F oreword . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . i v
1 S cope . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
3 Term s an d d efi n i ti on s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
4. 1 C om pon en ts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
4. 2 M ateri al s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
4. 3 D es i g n an d ch aracte ri s ti cs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
4. 4 S teri l i ty an d n on -p yrog en i ci ty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
6 Tes t m eth od s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
6. 5 Water-ti g h tn es s of th e co m p on en ts of th e d evi ce . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
6. 7 B ol u s vol u m e . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
6. 8 Refi l l ti m e. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
B i bl i og raph y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1
F oreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards bodies
(ISO member bodies). The work of preparing International Standards is normally carried out through ISO
technical committees. Each member body interested in a subject for which a technical committee has been
established has the right to be represented on that committee. International organizations, governmental and
non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely with the
International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.
International Standards are drafted in accordance with the rules given in the ISO/IEC Directives, Part 2.
The main task of technical committees is to prepare International Standards. Draft International Standards
adopted by the technical committees are circulated to the member bodies for voting. Publication as an
International Standard requires approval by at least 75 % of the member bodies casting a vote.
Attention is drawn to the possibility that some of the elements of this document may be the subject of patent
rights. ISO shall not be held responsible for identifying any or all such patent rights.
ISO 28620 was prepared by Technical Committee ISO/TC 76, Transfusion, infusion and injection equipment
d e vi ces
1 S cope
This International Standard specifies essential requirements and related test methods for non-electrically
driven portable infusion devices 1 ). It applies to devices designed for continuous (fixed or adjustable) flow
and/or for bolus application.
These devices can be used in health care and non-health care settings. They can be applied or administered
by health care professionals or by the intended patient.
These devices can be pre-filled by the manufacturer or filled before use by a health care professional or the
intended patient.
⎯ electrically driven or electrically controlled infusion pumps that are covered by IEC 60601 -2-24;
⎯ implantable devices;
⎯ devices where the energy for infusion is not provided by the device or through active intervention by the
patient (e.g. devices only powered by gravity).
The following referenced documents are indispensable for the application of this document. For dated
references, only the edition cited applies. For undated references, the latest edition of the referenced
document (including any amendments) applies.
ISO 594-1 , Conical fittings with a 6 % (Luer) taper for syringes, needles and certain other medical
ISO 594-2, Conical fittings with 6 % (Luer) taper for syringes, needles and certain other medical equipment —
ISO 1 5223-1 , Medical devices — Symbols to be used with medical device labels, labelling and information to
3 Term s an d d efi n i ti on s
For the purposes of this document, the following terms and definitions apply.
3. 1
b ol u s
3. 2
bol u s refi l l ti m e
time required to refill the emptied bolus device to the bolus volume
3. 3
n om i n al bol u s refi l l ti m e
3. 4
fi l l i n g vol u m e
3. 5
res i d u a l vol u m e
volume remaining in the device and applicable components, after completion of infusion
3. 6
ratio, in millilitres per hour (ml/h), between a volume administered and the time necessary to administer it
3. 7
m ean fl ow rate
ratio, in millilitres per hour (ml/h), between the nominal volume and the actual time for administration
3. 8
n om i n al ti m e
3. 9
n om i n al fl ow rate
ratio, in millilitres per hour (ml/h), between the nominal volume and nominal time
3. 1 0
n om i n al vol u m e
3. 1 1
n om i n al b ol u s vol u m e
3. 1 2
p ortabl e i n fu s i on d evi ce
equipment intended for the controlled infusion of liquids into the patient and intended to be carried or worn by
the patient
3. 1 3
p rotecti ve p ackag i n g
configuration of materials designed to prevent damage to the sterile barrier system and its contents from the
time of their assembly until the point of use
3. 1 4
minimum package that prevents ingress of microorganisms and allows aseptic presentation of the product at
the point of use
4. 1 C om pon en ts
⎯ a flow restrictor;
The device may also contain one or more of the following components (not an exhaustive list):
⎯ a sterility protector, e.g. Luer cap, at the distal end of the tubing and of the filling site;
⎯ a system to administer a bolus with a means for controlling the maximum amount of solution infused over
time;
⎯ a protective element of the reservoir, preventing the drug solution from flowing out should the reservoir
break or leak (that may be necessary to fulfill the leakage test in 6.4 and 6.5);
⎯ administration tubing;
⎯ an air-eliminating feature.
4. 2 M ateri al s
The materials used in the manufacture of the parts that come in contact with the drug solution shall have
undergone a biological evaluation according to the pertinent parts of ISO 1 0993.
4. 3 D es i g n an d ch aracteri sti cs
4. 3. 1 G en eral
All elements of the device designed to receive the drug shall constitute a closed, water-tight system. This
requirement shall be verified by the tests in accordance with 6.3, 6.4, 6.5 and 6.6.
If necessary, a redundant mechanism of the reservoir shall be available, minimizing the risk of leakage of the
solution from the reservoir.
4. 3. 2 F i tti n g s
If fittings at the distal end of the tubing are used they shall be interlocking male fittings.
If applicable, the fitting at the filling port shall be an interlocking female fitting.
All device fittings designed to be connected to other medical devices or to accessories shall comply with
ISO 594-1 and ISO 594-2.
4. 3. 3 F i l ter
The system shall include a particulate matter filter on the fluid path of the solution. Its pore size shall be less
than or equal to 1 5 µm.
4. 3. 4 Tu bi n g
If the device is designed with tubing it may be fixed or removable. If the tubing is removable, the connection
system to the device shall use an interlocking fitting. The junction between the reservoir and the tubing shall
resist a static traction of 1 5 N for 1 5 s.
4. 3. 5 Res e rvoi r
The reservoir of the device shall be designed so as to allow visual inspection of the solution.
4. 4 S teri l i ty an d n on -p yrog en i ci ty
All parts of the device in contact with the drug solution shall have been subjected to a validated sterilization
process and be delivered sterile and non-pyrogenic, and be for single use only.
5. 1 . 1 F l ow rate
Each nominal flow rate of the device shall be calibrated using control solutions at a given temperature. The
nominal flow rate as well as the control solutions and the temperatures shall be specified in the instructions for
use accompanying the device [see 8 c) and g)].
The mean flow rate shall have a tolerance of ±1 5 % compared to the nominal flow rate. The adjustable flow
rate shall have a tolerance of ±20 %. At least 80 % of the nominal volume shall be delivered at an
instantaneous flow rate within ±50 % of the nominal flow rate. These requirements shall be verified using the
test methods described in Clause 6.
NOTE The instantaneous flow rate can deviate by more than 50 % of the nominal flow rate if the device is exposed to
external pressure.
5. 1 . 2 B ol u s , i f ap p l i cab l e
The bolus volume shall be not more than 1 1 5 % of the nominal bolus volume (see 6.7).
Activating the bolus device after the nominal bolus refill time, the bolus volume shall be in the range of 50 % to
1 1 5 % of the nominal bolus volume.
Activating the bolus device one or more times prior to the nominal refill time shall not result in an accumulated
bolus volume of more than 1 50 % of the nominal bolus volume, applying the test method described in 6.8.
6 Tes t m eth od s
NOTE Except for particular indications, the following provisions are common and applicable before each test.
6. 1 . 1 Ap p a ratu s an d re ag en ts
N eed l e s , with sizes recommended by the manufacturer, or in the absence thereof, needles with
6. 1 . 1 . 1
6. 1 . 2 Op erati n g con d i ti on s
Prepare the device according to the instructions for use and accompanying documents [see 8 c)] so that the
solution can be administered.
Perform the tests at the conditions as specified by the manufacturer or, if not specified, at a temperature of
(23 ± 2) °C at (50 ± 5) % relative humidity, with ambient pressure between 86 kPa and 1 06 kPa with the
reservoir and the distal outlet at the same head height.
6. 1 . 3 E xp res s i on of res u l ts
6. 1 . 3 . 1 M ean fl ow rate
The mean flow rate, Qm , is determined by measuring the time, T, necessary for the device to deliver the
majority of the nominal volume, VN , of solution. This volume can be determined by the weight of the solution
delivered divided by its density.
Qm = V′/T (1 )
where
V′ = 0,75⋅ VN (2)
The instantaneous flow rates, Qi , are determined by the volume of the solution, Vn , delivered by the device
during regular time intervals, Tn , with Tn being 1 % of the nominal time.
Qi = Vn /Tn (3)
6. 1 . 3 . 3 Proces s i n g of th e re s u l ts
Plot the curves Qm and Qi = f( t) allowing the respective fluctuations of the mean flow rate to be calculated, as
well as the instantaneous flow rates on both sides of the characteristic straight line of the nominal flow rate,
QN , provided by the manufacturer.
Thus, determine the correlation between the differences between the measured value of the mean flow rate of
the nominal flow rate, and the various measured values of the instantaneous flow rates of the nominal flow
rate based on the requirements in 5.1 .
6. 2 . 1 Pri n ci p l e
The purpose of this test is to confirm that the difference between the mean flow rate, the instantaneous flow
rates and the nominal flow rate remains within the tolerances defined in 5.1 during the entire administration
time of the solution.
6. 2 . 2 Ap p a ratu s
Apparatus consisting of the elements shown in Figure 1 . A and B shall be positioned at the same level unless
otherwise specified by the manufacturer.
Ke y
1 device to be tested
2 additional components (administration tubing, needle etc.) required by the manufacturer
3 anti-evaporation fluid container
4 electronic scale with appropriate accuracy
5 data processing system
F i g u re 1 — D i ag ram m ati c represen tati on of th e app aratu s u sed for th e d eterm i n ati on of th e fl ow rate
The temperature conditions for the test shall be controlled by placing the entire device or the flow restrictor
within the controlled temperature environment or as specified by the manufacturer.
The distal end of the needle shall be at the same level of the reservoir unless specified otherwise by the
manufacturer.
6. 2 . 3 P roced u re
Perform the test with zero counter-pressure or with the counter-pressure indicated by the manufacturer.
NOTE Before starting flow, stabilization might be required following recommendation by the manufacturer.
Take measurements in accordance with 6.1 .3.2 until the solution initially present in the device is totally
delivered.
Apply perpendicularly to the device reservoir along its longest axis, a force of 1 50 N, for 5 s, using an adapted
assembly that has two hard parallel plates capable of covering the entire device reservoir.
At the end of the test after the pressure is removed, the device shall comply with the flow rate test in 6.2 and
with the leak-proof test described in 6.5.
Let the device filled with a dyed solution to nominal volume, fall twice from a height of one meter, unless
otherwise specified by the manufacturer, over a thick hardwood board (for example > 600 kg/m 3 ), positioning
the device once on its axis, then once perpendicular to its axis.
NOTE A suitable solution is one containing Patent Blue V2) 2 mg/1 00 ml.
At the end of this test the device shall comply with the leak-proof test described in 6.5.
Fill the device with dyed solution to nominal volume and after the drop test, immerse the device for 5 min in a
container of water.
NOTE A suitable solution is one containing Patent Blue V2) 2 mgl/1 00 ml.
Under the test conditions described above, the device shall remain watertight, and the solution in the
container shall not become coloured.
measurements.
6. 8 Refi l l ti m e
volume delivered.
6. 8 . 5 Repeat readings for both tests two additional times with the same device.
6. 8 . 6 Calculate the average of the three volume measures for both tests.
6. 8 . 7 The average bolus volumes shall be in the range of 50 % to 1 1 5 % of the nominal bolus volume for
the first test, and less than 75 % of the nominal bolus volume for the second test.
EXAMPLE If the nominal bolus volume is 5 ml the result of the second test should be no more than 3,75 ml.
The information given in Table 1 shall be on the sterile barrier system, the protective packaging and/or the
device, as indicated.
s ys tem packag i n g
The accompanying documents shall give information on at least the following points:
c) control solutions used to calibrate nominal flow rate, temperature (see 5.1 ), as well as possible counter-
pressure used at the distal end of the device;
e) drugs with which the device is known to the device manufacturer/producer to be incompatible;
f) if bolus is provided, bolus volume and time to refill the bolus device;
g) all other information needed for correct use of the device (e.g. parallel infusion, flow rate variation due to
temperature variation, flow rate variation due to partial fill or overfill of the reservoir);
h) counter-indications;
i) if appropriate:
⎯ modalities of disinfection;
⎯ a warning about the fact that the performance of the device is reached only with disposable device(s)
recommended by the manufacturer.
In addition, the results of device specific drug compatibility/stability studies should include at least:
⎯ diluents used;
⎯ temperature conditions;
⎯ stability time.
B i bl i og raph y
[2] ISO 1 0555-1 , Sterile, single-use intravascular catheters — Part 1 : General requirements
[3] ISO 1 1 1 35-1 , Sterilization of health care products — Ethylene oxide — Part 1 : Requirements for
development, validation and routine control of a sterilization process for medical devices
[5] ISO 1 1 607-1 , Packaging for terminally sterilized medical devices — Part 1 : Requirements for materials,
[6] ISO 1 4937, Sterilization of health care products — General requirements for characterization of a
sterilizing agent and the development, validation and routine control of a sterilization process for
medical devices
[7] ISO 1 7665-1 , Sterilization of health care products — Moist heat — Part 1 : Requirements for the
development, validation and routine control of a sterilization process for medical devices
[8] ISO 80369-1 , Small bore connectors for liquids and gases in healthcare applications — Part 1 :
General requirements
[9] IEC 60601 -2-24, Medical electrical equipment — Part 2-24: Particular requirements for the safety of
[1 2] EN 1 3868, Catheters — Test methods for kinking of single lumen catheters and medical tubing
[1 3] ANSI/AAMI ST67:2003, Sterilization of health care products — Requirements for products labeled
“STERILE”
[1 4] C APES , D.F. and ASIIMWE , D., Performance of selected flow-restricting infusion devices , Am J Health —
Syst Pharm., 55, pp. 351 -359, 1 998
[1 5] Commission Directive 2008/1 28/EC of 22 December 2008 laying down specific purity criteria
concerning colours for use in foodstuffs
I CS 1 1 . 0 40 . 2 0